AmeriFlex Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,300	Closed	-$9.75K	–	1073
2025 Q1	$9.75K	Hold	1,300	–	–	﹤0.01%	857
2024 Q4	$10.3K	Buy	+1,300	New	+$10.3K	﹤0.01%	772